THERATECHNOLOGIES INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 14241
 
  
 
C07K PEPTIDES 8128
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
  
 
A01J MANUFACTURE OF DAIRY PRODUCTS 116
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9334314 Peptide compounds derived from melanotransferrin and uses thereofOct 18, 12May 10, 16[A61K, C07K]
9073963 receptorApr 15, 09Jul 07, 15[A61K, C07K]
8871713 Formulations of growth hormone releasing factor (GRF) molecules with improved stabilityMar 14, 13Oct 28, 14[A61K]
8822413 Bifunctional hormone having alpha-MSH activity and natriuretic peptide activity and uses thereofJul 07, 08Sep 02, 14[A61K]
8481489 GH secretagogues and uses thereofSep 26, 08Jul 09, 13[A61K]
8435945 GH secretagogues and uses thereofSep 26, 08May 07, 13[A61K]
8361964 Growth hormone releasing factor (GRF) analogs and uses thereofApr 17, 12Jan 29, 13[A61K]
8314066 GH secretagogues and uses thereofOct 23, 07Nov 20, 12[A61K]
7893025 Use of growth hormone releasing factor analogs in treating patients suffering from wastingOct 20, 04Feb 22, 11[A61K]
7521530 receptorJun 11, 02Apr 21, 09[A61K, A01N, C07K, A61M]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0302,909 ASSESSMENT OF IGF-1 LEVELS IN HIV-INFECTED SUBJECTS AND USES THEREOFAbandonedJan 11, 12Nov 14, 13[G01N]
2012/0004,174 GH SECRETAGOGUES AND USES THEREOFAbandonedJul 07, 11Jan 05, 12[A61K, A61P]
2011/0105,390 SELECTION AND TREATMENT OF PATIENTS SUFFERING FROM WASTINGAbandonedJan 11, 11May 05, 11[A61K, A61P]
2010/0267,635 USE OF PROTEASE INHIBITORS AND GRF MOLECULES IN COMBINATION THERAPYAbandonedApr 20, 10Oct 21, 10[A61K, A61P]
2010/0267,636 USE OF CYTOCHROME P450-METABOLIZED DRUGS AND GRF MOLECULES IN COMBINATION THERAPYAbandonedApr 20, 10Oct 21, 10[A61K, A61P]
7538185 Glucagon-like peptide-1 analogs with long duration of actionExpiredJan 07, 05May 26, 09[A61K]
2009/0088,383 GH SECRETAGOGUES AND USES THEREOFAbandonedSep 26, 08Apr 02, 09[A61K, A61P]
2008/0249,017 PHARMACEUTICAL FORMULATIONS OF GHRH MOLECULESAbandonedApr 04, 08Oct 09, 08[A61K, A61P]
7414029 Antagonistic peptides of prostaglandin E2 receptor subtype EP4ExpiredOct 19, 04Aug 19, 08[A61K]
2006/0292,613 METHODS AND COMPOUNDS FOR PREVENTION AND TREATMENT OF ELEVATED INTRAOCULAR PRESSURE AND RELATED CONDITIONSAbandonedJul 12, 06Dec 28, 06[C07H, A61K, C12Q, C12P, G01N, C07K]
7094761 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditionsExpiredOct 28, 04Aug 22, 06[A61K]
7067488 Modified GLP-1 peptides with increased biological potencyExpiredSep 25, 03Jun 27, 06[A61K]
2005/0124,550 Compounds that modulate the glucagon response and uses thereofAbandonedJun 18, 04Jun 09, 05[A61K, C07K]
2005/0059,605 Chemically modified metabolites of regulatory peptides and methods of producing and using sameAbandonedJan 30, 04Mar 17, 05[A61K, C07K]
6864239 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditionsExpiredMar 27, 03Mar 08, 05[A61K]
2004/0171,534 GRF analogs with increased biological potencyAbandonedAug 07, 02Sep 02, 04[A61K, C07K]
2004/0023,853 Antagonistic peptides of prostaglandin E2 receptor subtype EP4AbandonedMay 23, 03Feb 05, 04[A61K, C07K]
2004/0023,882 PTH derivatives resistant to skin proteasesAbandonedMay 16, 03Feb 05, 04[A61K, C07K]
2003/0204,063 Modified biological peptides with increased potencyAbandonedMar 03, 03Oct 30, 03[C07K]
6194384 Long-acting galenical formulation for GRF peptidesExpiredAug 18, 98Feb 27, 01[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.